Lv2
166 积分 2023-03-22 加入
Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care
5天前
已关闭
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
14天前
已完结
Macular edema secondary to retinal vein occlusion in a real-life setting: a multicenter, nationwide, 3-year follow-up study
2个月前
已完结
Toxicity profile of anaplastic lymphoma kinase tyrosine kinase inhibitors for patients with non-small cell lung cancer: A systematic review and meta-analysis
2个月前
已完结
Contextualizing the Development of Anti-HER2 Therapies for Patients with Advanced Urothelial Carcinoma
5个月前
已关闭
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
5个月前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
6个月前
已完结
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study
6个月前
已完结
Advances in Systemic Therapy for Lung Cancer
6个月前
已关闭
Cutting edge therapies: A review of Food and Drug Administration‐ approved drugs for non‐small cell lung cancer
6个月前
已完结
皖公网安备34019202002308
